Blood additive solution for naval hospital guam

Ended Purchase Order Awarded Last action

Contract number
HT941025P0077
Awardee
Awarding agency
Obligated
$23,519

Award facts

Opportunity
Contract value 100% obligated
$23,519.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
621991 Blood and Organ Banks
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02110, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a purchase order to Haemonetics Corporation on March 25, 2025, for blood additive solutions to Naval Hospital Guam, with a firm fixed price of $23,519.25 and a completion date of June 30, 2025. Performance occurs in Boston, Massachusetts. The order procures 250 milliliters of Anticoagulant Citrate Phosphate Double Dextrose (CP2D) and 250 milliliters of Additive Solution Formula 3 (AS-3) nutrient solutions designed to preserve and extend the shelf life of red blood cells and platelets for use with Haemonetics' ACP 215 automated apheresis devices. The procurement was conducted as a sole source acquisition under FAR 13.501(a) following a special notice posted March 5, 2025.

Quick answers

Who was awarded contract HT941025P0077?

HT941025P0077 was awarded to Haemonetics Corporation by Defense Health Agency (Department of Defense) on March 25, 2025.

How much is contract HT941025P0077 worth?

The government has obligated $23,519 on HT941025P0077.

Was contract HT941025P0077 competed?

The extent of competition for HT941025P0077 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award